Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma
- 1 August 2011
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 82 (3) , 201-209
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3KCancer Cell, 2010
- Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimSCell Death & Disease, 2010
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor GrowthCell, 2010
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAFNature, 2010
- Coexisting NRAS and BRAF Mutations in Primary Familial Melanomas with Specific CDKN2A Germline AlterationsJournal of Investigative Dermatology, 2010
- A comprehensive catalogue of somatic mutations from a human cancer genomeNature, 2009
- Oncogenic B-RAF Negatively Regulates the Tumor Suppressor LKB1 to Promote Melanoma Cell ProliferationMolecular Cell, 2009
- Targeted cancer therapyNature, 2004
- Mutations of the BRAF gene in human cancerNature, 2002